Zion Market Research has published a new research report titled 'Generative AI in Healthcare Market By Component (Solutions and Services), By Function (Medical Imaging & Diagnostics, Drug Discovery & ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...
Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for OsteoarthritisSANDWICH, United Kingdom, July 07, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a ...
Novartis has acquired UK biotech Myricx for up to $1.5bn as global drugmakers invest inpromising biotech firms ahead expected ...
The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...
The acquisition would add to Vertex’s pipeline and potentially grow its annual revenue by $5 billion with the addition of ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Verified Investing on MSN
My trading game plan revealed - 07/06/2026: S&P 500 line in the sand, chip sell-off, biotech rotation and yen carry risk
Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...
A series of biotech acquisitions transpired in under 9 months — totaling more than $3.5 billion. The drugs behind them target ...
Island Pharmaceutical’s experimental drug will be used to treat patients in Uganda, as the African nation grapples with the ...
Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results